Home » Crucell and DSM Announce PER.C6 License Agreement with Ferring
Crucell and DSM Announce PER.C6 License Agreement with Ferring
Dutch biotechnology company Crucell N.V. and allied contract manufacturer DSM Biologics announced that they have signed a PER.C6 commercial license agreement with Ferring Pharmaceuticals. This license agreement allows Ferring to use the PER.C6 cell line in the field of women's healthcare. Financial details were not disclosed.
()a href="http://biz.yahoo.com/pz/050525/78854.html" target="_blank">Yahoo News
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May